INTRODUCTION
Allergen immunotherapy (AIT); It is a treatment method that ensures the
development of immunotolerance against allergens by administering the
allergen extract, which is determined to be clinically sensitive, at
regular intervals and in increasing doses(1,2). It is a treatment
alternative that should be considered in patients who do not have
adequate elimination of the allergy, which is especially sensitive, and
who do not respond adequately despite appropriate medical treatment, or
who need regular drug therapy for a long time. It consists of two main
phases, initiation and maintenance phases. Atopic dermatitis (AD) is a
chronic, inflammatory skin disease that usually starts in early
childhood and progresses with persistent itching .EH is a disease caused
by the herpes simplex virus (HSV) in approximately 3% of AD
patients.(3)Although local side effects are frequently observed during
and after SCIT application, systemic side effects can be encountered,
albeit rarely. We aimed to present a young female patient who was
diagnosed with AD and developed Eczema herpeticum after SCIT
application, in the light of the literature.